July 6, 2012 by Chain Drug Review
Issue 07-16-2012, Opinion
The Supreme Court’s decision to uphold the Affordable Care Act provides a greater degree of certainty for retail pharmacy operators and other health care providers, but it is far from the final word on the legislation’s ultimate impact. Don Bell, senior vice president of legal affairs and general counsel at the National Association of Chain
July 6, 2012 by Chain Drug Review
Issue 07-16-2012, Opinion
June 27, 2012 by Chain Drug Review
Issue 06-25-2012, News
LONDON — The business model that has long sustained the research-based pharmaceutical industry is faltering, with the steady stream of blockbuster medications that once characterized it drying up and competition from generics suppliers increasing as an unprecedented number of branded products lose patent protection. One of the first big drug makers to hit the so-called
June 27, 2012 by Chain Drug Review
Issue 06-25-2012, News
PHILADELPHIA — GlaxoSmithKline is changing the way it operates, both internally and in terms of how it interacts with other health care stakeholders. “We recognize that we cannot force-fit old business models in a new health care environment,” said Jack Bailey, senior vice president of policy, payers and vaccines for the company’s U.S. operations, at
June 27, 2012 by Chain Drug Review
Issue 06-25-2012, News
MOON TOWNSHIP, Pa. — Part of the solution to the problems of access and cost that beset the nation’s health care system can be found in greater use of over-the-counter medications, an insight on which GlaxoSmithKline Consumer Healthcare is acting. “Over-the-counter medications have a very important role to play in our health care system,” said
June 27, 2012 by Chain Drug Review
Issue 06-25-2012, News
MOON TOWNSHIP, Pa. — New products are the lifeblood of the consumer products business, and that’s as true in the over-the-counter drug category as in any other sector. As part of its push to become a bigger force in nonprescription medicines, GlaxoSmithKline Consumer Healthcare has put a premium on research and development. “We are banking
June 22, 2012 by Chain Drug Review
Issue 06-25-2012, News
MISSISSAUGA, Ontario — Frank Scorpiniti is now just over a year into his Canadian experience: 11 months as chief operating officer of the Katz Group and just four months in the chief executive officer position to which he was appointed after the retirement of former president and CEO Andy Giancamilli in February. That time has
June 22, 2012 by Chain Drug Review
Issue 06-25-2012, News
NEW YORK — With the fate of the health care reform law hanging in the balance, three of the country’s largest health insurers said they would maintain some Affordable Care Act benefits regardless of how the Supreme Court rules on it. But the companies said they would not continue coverage for pre-existing conditions. With the
June 22, 2012 by Chain Drug Review
Issue 06-25-2012, News
ALEXANDRIA, Va. — Retail pharmacy has the capacity to be one of the drivers of the transformation of health care, says Kathleen Jaeger, senior vice president of pharmacy care and patient advocacy at the National Association of Chain Drug Stores. “Pharmacy can play a pivotal role by defining new roles and services that the health
June 21, 2012 by Chain Drug Review
Issue 06-25-2012, News
BENTONVILLE, Ark. — Walmart’s annual meeting earlier this month managed to celebrate the retailer’s 50 years of spectacular growth in usual style, with plenty of enthusiastic associates from around the world and high-profile celebrities on display. The final tally of shareholders’ votes on incumbent Walmart board members, however, demonstrated a significant level of discontent with
June 21, 2012 by Chain Drug Review
Issue 06-25-2012, News
DENVER — The National Association of Chain Drug Stores has unveiled an interactive educational resource for this year’s NACDS Marketplace Conference. In partnership with Inmar, a technology solutions company and associate member of NACDS, the trade group has launched the NACDS Marketplace Digital Learning Center to help retailers and suppliers gain an understanding of the
June 21, 2012 by Chain Drug Review
Issue 06-25-2012, News
DALLAS — The role of private label has changed, and that means a more sophisticated approach in developing them is required, according to Laura Sturdevant, Walgreen Co.’s director of product development for private brands. Sturdevant spoke at the Food Marketing Institute’s recent FMI 2012 show here, as part of a panel discussion called “Building Strong
June 21, 2012 by Chain Drug Review
Issue 06-25-2012, News
ALEXANDRIA, Va. — The National Association of Chain Drug Stores has named Thomas O’Donnell vice president of federal government affairs. O’Donnell, who most recently served as the chief of staff for Rep. Steve Rothman (D., N.J.), is slated to join the association on July 9. “We are thrilled that Tom will soon join NACDS’ highly
June 21, 2012 by Chain Drug Review
Issue 06-25-2012, News
MIAMI — Navarro Discount Pharmacy has launched a Spanish-language version of its website. Visitors to navarro.com can click on the "En Español" icon on the site’s home page to change the site’s language to Spanish. “The new Spanish language content allows us to better serve loyal customers already familiar with the Navarro brand and reach